BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
- Unique Entity ID (UEI)
- UA43HWRNXFS3
- Parent company
- BASILEA PHARMACEUTICA AG (UEI Z9A6DMV55YP3)
- Registered address
- ALLSCHWIL
- Other names on record
- BASILEA PHARMACEUTICA INTERNATIONAL AG; BASILEA PHARMACEUTICA INTERNATIONAL LTD ALLSCHWIL
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 17, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027: $0
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $0 |
| District where the work is done | Contract dollars |
|---|---|
| PA-06Chrissy Houlahan | $0 |
Fiscal year 2026: $52,683,131.14
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $52,683,131.14 |
| District where the work is done | Contract dollars |
|---|---|
| PA-06Chrissy Houlahan | $24,870,405 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| 75A50124C00033THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | Not published yet | $122,501,232 | Ends March 31, 2032 |
| HHSO100201600002CIGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | Not published yet | $108,445,186.87 | Ends April 18, 2026 |
| 75A50123C00050VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS. | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | MALVERN, PA-06 | $45,192,122 | Ends December 31, 2027 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.